Cronos Group Shareholders Approve Director Elections, Compensation
Cronos Group Inc. recently announced the results of its Annual Meeting of Shareholders, held on June 20, 2025. Key decisions were made, reflecting investor confidence and providing insights into the company’s strategic direction within the evolving cannabis market.
Shareholder Voting Outcomes
Shareholders, accounting for 71.87% of all outstanding common shares, participated in the meeting. They voted on several critical matters, including the election of directors and an advisory vote on executive compensation. All director nominees, as listed in the company’s definitive proxy statement from April 25, 2025, secured their positions with substantial support.
Michael Gorenstein, Jason Adler, Murray Garnick, Kamran Khan, Dominik Meier, Elizabeth Seegar, and James Rudyk were re-elected, each garnering over 92.3% of the votes in their favor. The detailed results of the votes for each director are as follows:
- Michael Gorenstein: 92.38% voted in favor
- Jason Adler: 96.61% voted in favor
- Murray Garnick: 96.56% voted in favor
- Kamran Khan: 96.92% voted in favor
- Dominik Meier: 96.94% voted in favor
- Elizabeth Seegar: 94.60% voted in favor
- James Rudyk: 96.74% voted in favor
Additional Approvals
Shareholders also approved, with 94.13% in favor, a non-binding advisory resolution concerning the compensation of the company’s named executive officers. Furthermore, they ratified the appointment of Davidson & Company LLP as Cronos’ independent auditor for the 2025 fiscal year. The board of directors has been authorized to set the auditor’s remuneration.
For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at www.sedarplus.com and the Company’s Form 8-K filed on EDGAR at www.sec.gov/edgar.
About Cronos
Cronos, a global cannabinoid company, aims to develop disruptive intellectual property. The company is working to advance cannabis research, technology, and product development. Their brand portfolio comprises Spinach®, PEACE NATURALS®, and Lord Jones®. The cannabis industry continues to grow, with global sales projected to reach $70.6 billion by 2028 (Grand View Research).
For further information, please contact: Harrison Aaron, Investor Relations at (416) 504-0004 or investor.relations@thecronosgroup.com.
